US FDA accepts MS drug Lemtrada resubmission for review
US FDA accepts MS drug Lemtrada resubmission for review
The US Food and Drug Administration (FDA) has accepted for review the Genzyme's resubmission of supplemental Biologics License Application (sBLA) seeking approval of Lemtrada (alemtuzumab) for the treatment of relapsing forms of multiple sclerosis. A six-month review period has been assigned for the Lemtrada sBLA. Genzyme expects FDA action on the sBLA in the fourth quarter...... Read More - http://www.ms-uk.org/lemtrada
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1942 Views
-
Last post by frodo
-
- 0 Replies
- 1698 Views
-
Last post by frodo
-
- 0 Replies
- 1311 Views
-
Last post by NHE
-
- 1 Replies
- 1792 Views
-
Last post by frodo
-
- 0 Replies
- 2109 Views
-
Last post by NHE
-
- 0 Replies
- 1245 Views
-
Last post by frodo
-
- 0 Replies
- 2521 Views
-
Last post by NHE
-
- 1 Replies
- 1508 Views
-
Last post by NHE
-
- 0 Replies
- 1851 Views
-
Last post by frodo